NEXGEL, INC.
USUSDNEXGEL, INC. (US:NXGL) — Medical/Dental Instruments. Anzahl der Börsen, an denen die Aktien des Unternehmens gehandelt werden: 1. Auf dieser Seite: Kurs und Chart, Dividenden, größte Aktionäre und Entwicklung der Aktienanzahl.
Über das Unternehmen
- Website
- nexgel.com
- Investor Relations
- ir.nexgel.com/
- Sektor
- Health Care · Medical/Dental Instruments
- Hauptsitz
- LANGHORNE, United States
- CEO
- Mr. Brian J. Kieser C.P.A.
- Mitarbeiter
- 19
- Ausstehende Aktien
- Streubesitz
- 7.7 Mio.
- Marktkapitalisierung
- 1.74 Mio. USD
- Insider
- 14.02%
- Institutionelle Anleger
- 13.67%
- Branche (SIC)
- Surgical & Medical Instruments & Apparatus
Beschreibung
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Börsen und Ticker
| Börse | Ticker | Währung | Preis | Typ |
|---|---|---|---|---|
| US USA Stocks | NXGL | USD | 0.1772 +2.49% | Stammaktie |
Dividenden
Keine Dividendenzahlungen gefunden (geprüft 08.10.2026). Das Unternehmen schüttet wahrscheinlich keine Dividenden aus.
Neuigkeiten diese Woche
Keine Nachrichten in der letzten Woche. Neueste Nachrichten: 23.09.2026.
Größte Anteilseigner
| Inhaber | Anteil | Aktien | Berichtsdatum |
|---|---|---|---|
| STEIN JOHN NACHUM (Direc… | ≈4.82% | 471 456 | 2024-11-20 |
| LEVY ADAM R (Chief Execu… | ≈3.3% | 322 692 | 2026-06-23 |
| GLASSMAN STEVEN MARK (Di… | ≈1.6% | 156 655 | 2025-02-12 |
| HENRY SCOTT ROBERT (Dire… | ≈1.16% | 113 356 | 2025-10-03 |
| ZELDIS JEROME B. M.D., P… | ≈1.09% | 106 664 | 2024-11-20 |
| Susquehanna Internationa… | 0.87% | 85 140 | 2026-06-30 |
| Virtu Financial LLC | 0.81% | 79 128 | 2026-06-30 |
| Geode Capital Management… | 0.74% | 71 863 | 2026-06-30 |
| HRT Financial LP | 0.71% | 69 485 | 2026-06-30 |
| Morgan Stanley | 0.56% | 54 980 | 2026-06-30 |
| Vanguard Capital Managem… | 0.5% | 48 920 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.5% | 48 920 | 2026-06-30 |
| Fidelity Concord Street… | 0.46% | 44 564 | 2026-07-31 |
| Citadel Advisors Llc | 0.42% | 40 976 | 2026-06-30 |
| Vanguard Fiduciary Trust… | 0.35% | 34 040 | 2026-06-30 |
| UBS Group AG | 0.25% | 24 735 | 2026-06-30 |
| Jane Street Group, LLC | 0.21% | 20 606 | 2026-06-30 |
| Fidelity Concord Street… | 0.14% | 13 583 | 2026-07-31 |
| Fidelity Concord Street… | 0.09% | 8 676 | 2026-07-31 |
| Fidelity Concord Street… | 0.01% | 546 | 2026-07-31 |
| DFA INVESTMENT DIMENSION… | 0% | 198 | 2026-07-31 |
| DFA INVESTMENT DIMENSION… | 0% | 152 | 2026-07-31 |
| Dimensional ETF Trust-Di… | 0% | 144 | 2026-07-31 |
| DRAPCZUK ADAM III (Chief… | — | — | 2024-11-20 |
